Pharma Trading Company Seeking Funds for Expansion

Established in 2020, a growing pharma trading unit specializing in diabetic care medicines is looking for working capital to scale operations. The medicines, manufactured through third-party agreements, are distributed under the company’s own brand name. With a robust network of 150 medical stores and partnerships with leading doctors, the business has established a solid foothold in the market. This funding will enable the unit to expand its reach, enhance inventory, and cater to increasing demand in the rapidly growing diabetic care segment. This is a promising opportunity to support a flourishing venture in the pharmaceutical industry.